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OSTEOPOROSIS: COMPARISON OF GENETIC AND ENVIRONMENTAL 




 Osteoporosis has affected millions of patients worldwide and is a continuing 
concern for the increasing ageing population. It is a skeletal disease due to abnormal bone 
growth and resorption, characterized by low bone mass. Onset could be due to genetics 
and family history or acquired risk factors like lifestyle, diet, and exercise. As a result, it 
is important to try to understand the mechanisms of the onset of low bone mineral density 
so that effective treatment plans and prevention methods can be determined.  
 The purpose of this study is to compare how the genetic makeup of an individual 
interacts with one’s environment in the determination of bone mineral density (BMD) 
and the onset of osteoporosis. This study focused on comparing biochemical markers of 
osteogenic cells and their mineralization potential between primary and secondary 
cultures of mesenchymal stem cells (MSC) that were harvested from pelvic bone-marrow 
remains of patients undergoing hip replacement. We hypothesized that the primary 
cultures grown out directly after being acquired; should be impacted more directly by 
comorbidities present at the time of collection while the secondary cultures expanded 
from the initial marrow stromal cells should show less impact of comorbidities and 
reflect more closely genetic aspects that affect BMD. It was found that while the 
secondary cultures overall produced greater values for DNA, ALP, calcium, 
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hydroxyproline, and protein, when samples were normalized the values between the 
primary and secondary cultures did not show significant differences. This data appeared 
however to validate our hypothesis since the overall increased growth and mineralization 
of the secondary cultures showed a loss in their overall correlation to the environmental 
impacts of smoking and BMI that were observed in the primary cultures. 
 The second hypothesis explored the specific correlations between the biochemical 
markers as indices of osteogenic potential of the cultures (DNA, ALP, calcium, 
hydroxyproline, and total protein) in relation to each other. The hypothesis was mostly 
supported with positive correlations, between all the features except for that between 
hydroxyproline and calcium which showed a negative correlation. 
 Overall, this study demonstrates that although the normalized values between the 
primary and secondary cultures did not show significant different osteogenic features; it 
did show the correlations to comorbidities identified in primary cultures were lost upon 
expansion following sub cultivation. Further studies with larger sample sizes are needed 
which will provide a more statistically significant conclusion, allowing for further 
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 Osteoporosis is a disorder characterized by the decrease in bone mass, 
microarchitectural deterioration, and increased likelihood of fractures. (Lane, Russel, & 
Khan, 2000). It affects approximately slightly more than 10 million Americans today and 
is projected to affect more than 14 million by 2020 (Lane, 2006). As the aging population 
increases, there will be an increase in incidence rates as older patients are more 
susceptible to fractures (Ettinger, 2003).  
Bone Physiology  
Osteoblasts, Osteoclasts, and Osteocytes Bone is a specialized type of 
connective tissue composed of three major cells, osteocytes, osteoblasts, and osteoclasts. 
These cells interact together to remodel the bone throughout life, as they find balance 
between bone resorption and bone formation. Osteoblasts are cells that create the bone 
matrix (Mescher, 2016). Osteoblasts are derived from and maintained by osteoprogenitor 
cells, which arise from multipotent stem cells within the bone marrow called 
mesenchymal stem cells. Different from hematopoietic stem cells, mesenchymal stem 
cells are what give rise to bone, cartilage, fat, and fibrous connective tissue. Once fully 
differentiated, they secrete type I collagen and other proteins that are necessary for bone 
formation (Clarke, 2008). Osteoclasts are multinucleated cells that are derived from the 
myeloid lineage and break down, remove, and remodel calcified bone tissue and matrix 
(Mescher, 2016). There are two cytokines that are important for osteoclast formation, 
which are RANKL and macrophage CSF. They are produced mainly by marrow stromal 
cells, osteoblasts and osteocytes. For bone resorption to occur properly, it depends on 
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osteoclasts to secrete hydrogen ions and cathepsin K enzyme, as the hydrogen ions 
acidify the resorption pit under the osteoclast, which is in the process of dissolving and 
reabsorbing the mineral components of the bone matrix. The cathepsin K activates 
proteases which in turn activate collagenases that digest the type I collagen component of 
the matrix (Clarke, 2008). Osteocytes are terminally differentiated osteoblasts that have 
become surrounded by the mineralized matrix that they have synthesized exists within 
lacunae (Mescher, 2016). These cells are the most abundant cells of bone tissue and they 
support the structure of bone and its metabolism (Clarke, 2008). They also are the 
primary mediators of both mechanical signals that control bone structure and produce the 
major regulators that control osteoclastogenesis (Pajevic, 2019).  
Osteogenesis Osteogenesis is the process of bone development, which can occur 
by two processes. Intramembranous ossification is the process by which differentiated 
osteoblasts from mesenchyme start to secrete osteoid (Mescher, 2016). Through this 
process, flat bones of the skull form. It begins with neural crest-derived mesenchymal 
cells proliferating and condensing into compact nodules. Osteoblasts then start to secrete 
collagen into the matrix that allows calcium salts to bind and calcify. As the osteoblasts 
continue to secrete matrix and it continues to mineralize, they become encased in their 
matrix and become osteocytes. As the calcified areas become surrounded by other 
mesenchymal cells, it begins to form the periosteum, which is a membrane that surrounds 
the bone. For the cells on the inner side of the periosteum, they differentiate into 
osteoblasts and also lay down the matrix, thus creating more layers of the bone (Gilbert, 
2000). Endochondral ossification is a bone forming process in which nascent skeletal 
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organs are first modeled in cartilage. Mesenchymal cells surround the central regions of 
a cartilage model then differentiate into osteoblasts and follow the same progression of 
development as seen in the calvaria. Bone tissues form a bony color around the central 
regions of the cartilage models. This region is then perforated with a feeding blood vessel 
bringing in osteoblasts that invade the existing cartilage templates of bone, leading to the 
resorption of the cartilage. The osteoid production in this space forms trabecular bone, 
which will eventually form in the marrow spaces of most appendicular and axial bones.  
When bone is formed, it first creates a woven structure that is then replaced by a 
stronger and lamellar bone (Mescher, 2016). Endochondral ossification can be broken 
down into five stages. In the first stage, the mesenchymal cells are committed to 
becoming cartilage cells due to paracrine factors from mesodermal cells that cause two 
transcription factors to be expressed, Pax1 and Scleraxis. Next, the committed 
mesenchyme cells  differentiates toward chondrocytes which then forms a model of bone 
by secreting cartilage into the extracellular matrix. In the fourth part of this process, the 
chondrocytes then stop proliferating and progress to hypertrophic chondrocytes. These 
are chondrocytes that produce collagen and fibronectin that allow the matrix to become 
mineralized. The final stage of endochondral ossification is blood vessels invading the 
cartilage, which then leads to the hypertrophic chondrocytes to apoptosis and creating a 
space called the bone marrow (Gilbert, 2000). 
Biochemical Markers of Bone Formation and Turnover The bone is made of 
mineral, organic matrix, water, and lipids. Hydroxyapatite, a crystalline calcium 
phosphate salt is the primary mineralized portion of the bone matrix (Clarke, 2008). 
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Important determinants of bone mineralization are serum calcium, inorganic phosphate, 
and having a collagen-rich extracellular matrix (Murshed, 2018). Important to the 
mineralization process is ionic calcium and inorganic phosphate concentrations. Lower 
levels of these minerals can lead to greatly decreased amounts of mineralization, which 
could be affected by the levels of vitamin D. Vitamin D is an important factor that allows 
for absorption of ionic calcium (Murshed, 2018). Its major function is to optimize the 
absorption of intestinal calcium and phosphorus that are vital for the formation of the 
bone mineral matrix. Vitamin D-dependent calcium transport proteins that regulate this 
calcium absorption through the intestine includes the transient receptor potential cation 
channel, subfamily V, member 6 (TRPV6). It is this channel that allows calcium to enter 
the enterocytes of the intestines and is highly regulated by 1,25(OH)2D. As women age, 
the TRPV6 levels decline which contributes to the decrease in calcium absorption. 
Therefore, maintaining optimal vitamin D levels is so important so that calcium could be 
efficiently absorbed. The presence of vitamin D allows for intestinal calcium to be 
absorbed at a 30%-40% rate, while the absence only allows for 10%-15% absorption. 
Through studies with rodent models, it was found that mice without the vitamin D 
receptor eventually developed osteomalacia. This finding suggested that vitamin D is 
vital to increase calcium reabsorption through the intestine allowing for  bone 
mineralization to properly happen (Khazai, 2008). In the process of bone formation and 
mineralization, osteoblasts release alkaline phosphatase and other proteins are expressed 
(Clarke, 2008). The alkaline phosphatase is attached to the osteoblast cell membrane, and 
can cleave inorganic pyrophosphate, which is a strong mineralization inhibitor, releasing 
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free inorganic phosphate ions thus allowing mineralization to occur (Murshed, 2018). 
During bone turnover, also known as bone resorption, hydroxyproline is released when 
type I collagen is broken down. However, it is also understood that hydroxyproline is 
associated with osteoblast activity, as some newly created collagen chains are degraded 
before they are secreted by osteoblasts (Schönau and Frank, 2003). These biochemical 
markers can then be used to predict the rate of both bone loss in patients and their risk for 
developing osteoporosis (Swaminathan, 2001).  
Types of Bones Throughout the body, there are several types of bones. The 
woven bone is a newly calcified bone that is found in developing and growing bones or 
when a hard callus forms during bone fracture healing. It is also known as an immature 
bone. The lamellar bone is a type of remodeled woven bone that is found throughout 
adult bones. It is also known as a mature bone. The compact bone, which comprises 
about 80% of lamellar bones, are the outer region of bones, also known as the cortical 
bone. The cancellous bone is what makes up the other 20% of lamellar bones. It is the 
inner region of bones, which are next to the marrow cavities and is also called the spongy 
bone (Mescher, 2016).  
Osteoporosis  
Pathogenesis Osteoporosis is a skeletal disorder due to an imbalance in bone 
remodeling, leading to increased susceptibility of fractures as well as reduced strength in 
bones. The two factors that lead to diagnosis of osteoporosis are failure of the bone to 
reach peak mass and having excessive amounts of bone resorption or a decrease in bone 
formation during bone remodeling. Not reaching peak bone mass can lead to osteoporosis 
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and fractures, which are most impacted by genetic factors. Some of the genetic variants 
that regulate bone mass are lipoprotein receptor-related protein 5, sclerostin, 
osteoprotegerin, oestrogen receptor 1, and receptor activator of RANK pathway genes 
(Sandhu, 2011). Furthermore, having an imbalance in bone remodeling can create 
damage to the integrity of the bone structure. The most important regulators and 
mediators of osteoblast activity is LRP5, while the most important mediator for osteoclast 
activity is OPG/RANK and its ligand RANKL, as the OPG/RANKL ratio is vital to 
maintain normal bone mass and strength, growth hormones, cytokines, and drugs affect 
their expressions. Hormones like estrogen affect bone remodeling and with a deficiency, 
it can lead to abnormal bone turnover and lead to osteoporosis (Sandhu, 2011). Women 
who are older and post-menopausal tend to have abnormalities in bone remodeling 
processes that increase the likelihood of fractures. This is due to the estrogen deficiency 
caused after menopause which accelerates bone loss, increasing the risk of fractures. A 
decrease in estrogen levels leads to having greater bone resorption and less bone building. 
(Lane, 2006). Age also plays a large role in increased resorption and decreased bone 
formation, leading to bone loss and fractures. This is thought to be due to the lack of 
osteoprogenitor cells differentiating into osteoblasts with increasing age, as they tend to 
differentiate into adipocytes (Sandhu, 2011).  
 Diagnosis When diagnosing osteoporosis, it is asymptomatic and difficult to 
diagnose until the bone fails when under physical stress (Dobbs, 1999). However, when 
detected, a way to diagnose osteoporosis is to measure bone mineral density (BMD) by 
using a dual X-ray absorptiometry. To measure BMD, the spine and hip are usually 
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analyzed; however, if unable to reach the spine and hip, the forearm can also be used to 
measure BMD (Sandhu, 2011). Being able to measure BMD and finding low bone mass 
is one of the most accurate predictors for increased fracture risk (Smith, 2000). 
According to the NIH, the BMD test results give the patient a T-score and compared to a 
healthy adult. A normal T-score is between +1 and -1. When diagnosed with low bone 
mass, it is between -1 to -2.5. To be diagnosed with osteoporosis, a patient will receive a 
T-score of -2.5 or lower. A case of severe osteoporosis will however score a greater 
negative score than -2.5. This means the patient has had one or more osteoporotic 
fractures previously (NIH,2018). Another method of diagnosis is by going over a 
patient’s history of fragility fracture, since prior fractures can also lead to a diagnosis of 
osteoporosis (Sandhu, 2011). Further evaluation should also note whether they have 
secondary osteoporosis due to other diseases like hyperthyroidism, Cushing’s disease, or 
drugs and treatments that may lead to osteoporosis and lowered bone mineral density 
(Dobbs, 1999).  
Risk Factors Risk factors that are associated with inducing osteoporotic fractures 
are hormonal factors, use of certain drugs, low physical activity, low levels of calcium 
and vitamin D, race, body size, and familial history of fracture incidences (Lane, 2006). 
Behavioral environmental factors that impact peak bone mass are smoking and alcohol 
consumption (Sandhu, 2011). It has further been found that the effects of smoking on 
bone metabolism are exacerbated by alcohol consumption. Large amounts of alcohol 
consumption alone result in increased risk of fractures for both men and women and bone 
histological examinations have shown physical changes to bone structure of those who 
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consume large amounts of alcohol. Alcohol is known to suppress the function of 
osteoblasts, suppressing and decreasing bone mineralization. As a result, it can cause 
calcium to be excreted in urine causing hypercalciuria and lowered serum levels of 
calcium, causing hypocalcaemia and reduced BMD. Effects on bone metabolism due to 
alcohol can result from the effects alcohol has on other organs such as liver damage, 
hypogonadism and nutritional deficiencies (Metcalfe, 2008).  
Low levels of hormones like estrogen in women and testosterone in men can lead 
to increased risk for osteoporosis. Low estrogen levels in women can occur after 
menopause or in abnormal cases of extremely low levels of estrogen pre-menopause. For 
men, as testosterone gradually decreases with age, it may not play as large of a role in 
decreases of BMD (NIH, 2019). Certain drugs and medications like glucocorticoid 
steroids and cancer medications may increase the risk of osteoporosis. Other drugs like 
Thiazolidinediones and selective serotonin reuptake inhibitors may also contribute to the 
decrease in BMD and risk for osteoporosis (NIH, 2019). 
Ethnicity and race play a large role as well. Women who are Asian and non-
Hispanic are more at risk than African American and Hispanic women. Overall, the 
demographics of patients who are more likely to be affected by osteoporosis are generally 
the older population, especially women a few years before menopause. For men, 
osteoporosis is more common among non-Hispanic whites (NIH, 2019). A patient’s body 
size also plays a role in the risk of osteoporosis. Women and men who are thinner-boned 
and slim are at greater risk than those who are thicker-boned. It has also been shown that 
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patients with parents who have a history of osteoporosis or hip fractures are more likely 
to be at risk for osteoporosis (NIH, 2019).  
Common Osteoporotic Fractures About 51% of women and 24% of men have 
fractures as a result of osteoporosis. 250,000 of these cases are hip fractures (Metcalfe, 
2008). Hip fractures are one of the most frequently occurring osteoporotic fractures, with 
a 20% occurrence rate (Pouresmaeli, 2018). The hip is a multiaxial ball-and-socket 
synovial joint where the head of the femur articulates with the concave acetabulum of the 
pelvis. The joint is covered by a dense layer of articular hyaline cartilage and the primary 
function is to sustain body weight when moving and static. The femoral head is supported 
by a thin femoral neck, which is prone to fractures. It is more prone when a patient 
suffers from bone disorders such as osteomalacia, osteogenesis imperfecta, and metabolic 
bone diseases. However, most patients who fracture the femoral neck suffer from 
osteoporosis (Metcalfe, 2008). In addition to physical and economic burden, hip fractures 
cause patients to be dependent on others. About 50% of patients with hip fractures 
require assistance when walking and then another 25% requiring domiciliary care after 
(Metcalfe, 2008). In addition, fracture of the proximal femur is associated with an 8%-
36% mortality rate, with a higher rate among men than women. This rate is only 
increasing as the ageing population continues to increase every year (Pouresmaeli, 2018). 
Another common osteoporotic fracture is the fracture of the distal forearm. Around 18% 
of patients who were over the age of 65 had osteoporotic fractures of the forearms, while 
those who fractured their forearms, 75% of them were a result of osteoporosis 
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(Pouresmaeili, 2018). Other types of common osteoporotic fractures include vertebral, 
pelvic, and closed fractures of the humerus, radius, and ulna (Warriner, 2010).  
Types of Osteoporosis There are presently two categories of osteoporosis. 
Primary osteoporosis is the more common form which includes osteoporosis occuring in 
post-menopausal women. Secondary osteoporosis is a result from medical disorders that 
affects a patient’s bone mineral density as well as senile osteoporosis. Senile osteoporosis 
is due to a clear and definable etiologic mechanism, while primary (type I) is associated 
with reduced hormones leading to increased bone resorption. Furthermore, secondary 
osteoporosis (type II) occurs with gradual aging where there is a loss of stem-cell 
precursors, therefore a loss of bone growth and loss of bone (Dobbs, 1999). Some 
disorders include gastrointestinal diseases, hematologic disorders, and even hypogonadal 
states. Another factor could be a result of the medications taken when treating these 
diseases, such as glucocorticoids. Glucocorticoids affect the quantity and quality of bone, 
which could increase the risk of fractures in patients as a result of decreased bone mineral 
density (Lane, 2006). 
Prevention and Treatment As it is increasingly affecting the ageing population, 
it is important to find ways in preventing and treating osteoporosis. Some treatments 
include preventing fractures and modifying general lifestyles that can reduce 
susceptibility to fractures. For example, optimizing the intake of calcium and vitamin D 
(Sandhu, 2011). It is recommended to eat a healthy diet of foods like fruits and 
vegetables that are rich in calcium, vitamin D, and protein. Practicing a healthy and 
balanced diet can help maintain not only overall health of a patient, but also minimize the 
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loss in bone and decrease of BMD (NIH, 2019). Foods that are rich in vitamin D include 
low-fat dairy products, dark green leafy vegetables, broccoli, and salmon. Vitamin D is 
important for minimizing loss in bone due to its role in absorbing calcium from the 
intestine (NIH, 2019). Furthermore, according to the NIH, steps and precautions that can 
be taken to prevent the onset of osteoporosis and fractures is by staying physically active, 
drinking alcohol in moderation, not smoking, and eating foods rich in calcium and 
vitamin D (NIH, 2019). Other treatment options to maintain and sustain osteoporotic 
fractures include encouraging weight-bearing exercise, intaking adequate calcium levels, 
exercise, and frequent physical examinations. It is recommended for patients 65 years and 
older to intake 400-800 IU/day of Vitamin D. For calcium, it is recommended that 
patients who are 4 years and older have an intake of 1000-15000 mg/day. For patients 
who are estrogen deficient, it is recommended to also have an estrogen intake of 0.625 
mg/day or transdermal estradiol of 0.05 mg/day (Dobbs, 1999).  
Present Study 
This study investigates how genetic disposition and preexisting environmental 
comorbidities affects osteogenic bone cell growth and metabolic activity in vitro. It 
assesses the relationship between primary and secondary growth of bone marrow 
osteogenic cells in culture to the expression of osteogenic functions. The factors that are 
investigated relative in vitro osteogenic growth and activity are sex, age, race, BMI, 
vitamin D level, renal disease status, and smoker status.  
 
Hypothesis: The first hypothesis is that comorbidities present at the time of 
marrow collection will have a greater impact on the primary cultures of a patient’s 
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mesenchymal stem cells osteogenic ability than seen in sub cultivated cultures. The 
second hypothesis is that there will be a greater positive correlation between specific 
biochemical markers within the secondary cultures of marrow stromal cells as the 
osteogenic cell population becomes more homogeneous. 
This study will provide more insight and understanding of osteoporosis by 
analyzing the biochemical markers of osteogenic bone cell growth and activity while 
considering various osteoporosis risk factors. It will shed light on those environmental 
comorbidities that have greatest effects on a patient’s MSCS osteogenic abilities 









Cell Culture Procedure 
 MSC Culture Methods For each patient two vials containing 2 x 107 frozen 
unfractionated total marrow cells were used for initial culture plating per one 100 mm 
cell culture plate. Each 100 mm plate was evenly coated with 6.5 mL Animal 
Component-Free (ACF) Cell Attachment Substrate (Stem Cell Technologies Inc Cat 
#07130). The plates were then incubated for at least 2 hours at room temperature under 
UV lights in a Biocontainment tissue culture hood. The substrate was then aspirated off 
and the plate was washed with 10 mL of Dulbecco’s phosphate-buffered saline (DPBS). 
 Two vials per patient frozen stocks of marrow were thawed in a 37°C water bath. 
Once they were thawed cell solutions were placed into 10 mL of artificial media, 
Mesencult-ACF Plus Medium (Stem Cell Technologies Inc Cat #05445) made 1X with 
Mesencult-ACF Plus 500X Supplement (Stem cell Technologies Inc Cat #05447). This 
media was then made to a final of 2 mM L-Glutamine and 1X with an antibiotic-
antimycotic solution (Life Sciences Inc.). The cell suspensions were then thoroughly 
dispersed by vortex mixing for 10 second and pelleted by centrifugation at 1150 RPM for 
5 minutes. The artificial media was aspirated off carefully and the cells were suspended 
in a new 10 mL of the above media.   
 Each patient sample was seeded in one 100mm culture plate that had been coated 
with attachment substrate as described above. The plates were then grown in a humidified 
incubator at 37°C 5% CO2. After 4-5 days, a half media change was performed by 
removing half the volume of media and replacing it with fresh stem cell culturing media. 
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A full media change was done one week after plating. Every 2-3 days thereafter the 
media was changed for 2 weeks. After 3 weeks of growth the cells were trypsinized and 
plated into 12-well plates and grown in α-MEM + 10% fetal bovine serum (FBS) + 1% 
Pen-Strep for 2 weeks. At this time, they were trypsinized and replated at 50,000 cells 
per/ 4 cm22 well of the 12-well plates. The growth media was then switched to 
osteoinductive media-MEM + 10% FBS + 1% Pen-Strep supplemented to a final 
concentration of with 8mM β-glycerophosphate, Dexamethasone 1x10-8 M and 12.5µg/ml 
ascorbate. After 21 days, the cells were harvested for sequential assays. The Alkaline 
Phosphatase (ALP) Assay and (Alizarin Red S) ARS Quantification Assays were 
performed directly on the wells in the dish on day 21. The ARS Quantification Assay was 
done directly on the 12th well of the plates. 
Biochemical Assays  
All plate assays were read in a BioTek Cytation 1 plate reader. Individual plate 
characteristics and background assays were predetermined for all assays. 
Alkaline Phosphatase Assay To run the assay, ALP assay buffer and ALP 
substrate were first prepared. The ALP assay buffer consisted of 0.01M glycine, 1mMgCl2 
made pH 10.5 using NaOH. The buffer was filtered and ready to use or stored at 4 ° C for 
up to 6 months. The ALP substrate was made on the day of the assay by dissolving 20 mg 
p-nitrophenol phosphate disodium salt (Sigma #4876-1gm) per ml deionized (DI) water. 
450μL of buffer and 50 microliters of substrate were added per well incubated in the dark 
for 30 minutes at room temperature. During incubation, a 96-well plate was set up to read 
for each set of ALP samples. Each plate was prepared containing a standard curve which 
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was prepared by diluting 10mM p-nitrophenol stock solution with the reaction buffer. 
Once 30 minutes of incubation was complete samples from each well were transferred to 
the 96-well plate containing the standards for assay (See Figure 1). To each well of the 96 
well-plate 500µl of 0.2M NaOH was added to stop the reaction. The absorbance was then 
read at 410nm.  
Figure 1- Standard Curve for ALP Assay. Representative image of ALP assay 
standard curve (Patient 231, 237) 
 
Cell Layer Extractions After removing the p-nitrophenyl phosphate, disodium 
salt (pNPP) solution from the sample plates, the plates were washed three times with 
1mL/well D-PBS to remove any residual pNPP solution.  Prior to harvesting the wells, 
one of the wells was set aside overlaid with D-PBS to run the Alizarin Red S Assay.  
To make 100mL of the extraction buffer, 38.17g of 4M Guanidine-HCl, 1mL of 1% 
Triton X-100 lysis buffer, 5 mL of 1x TE buffer pH 7.4 (20x solution, 200mM Tris-HCl, 
and 20mM EDTA) were dissolved in 100mL of DI water. To each sample well, 100-
microliters of the extraction buffer was added and placed on a shaker for 30 minutes. 














with patient number and individual well numbers with 100-L of ultrapure H2O. After 30 
minutes, a mini cell scraper was used to scrape the sample well plates. The insoluble 
material and extraction buffer were then transferred to 2mL pressure-tight 
microcentrifuge tubes. They were then stored in -80˚C freezer until ready to proceed to 
the subsequent assays.  
Alizarin Red S Quantification Assay To prepare the Alizarin Red Solution 
(2%), 2g Alizarin Red S (Acros Organics, Fisher #AC400481000) was dissolved in DI 
water per 100mL. The pH was then adjusted to 4 using 1% ammonium hydroxide 
solution and filtered. Fresh solutions were made every 2 weeks and stored at 4˚C. For the 
one well that was not harvested and side aside, the D-PBS was aspirated off. Then 2mL 
of 2% paraformaldehyde (PFA) is added to each well for 20 minutes. Afterwards, the 2% 
PFA was aspirated off and washed with D-PBS 3x. 2mL of 2% Alizarin Red Solution 
was then added to each well and left for 30 minutes. The solution was then aspirated off 
and washed 3x with D-PBS and 1x with DI water. Images of the nodules were taken and 
scored based on evidence of mineralization (See Figure 2). 
Figure 2- Representative Qualitative Alizarin Red Nodule Assay Staining Scale Each 
stain was scored between 0 and 2. 0= no mineralization, 1= partial well mineralization, 
2= uniform and complete mineralization (a) Patient 226, Score: 1 (b) Patient 232, Score: 
1 (c) Patient 240, Score: 2 
 




DNA Assay The DNA assay was run first to minimize the effects of DNAses and 
since these assays required the smallest amount of sample. For these fluorescent assays 
black 96-well microplates were used. Prior to running the DNA Assay, the samples 
stored in -80˚C were retrieved and thawed on ice. Once the samples were thawed, they 
were spun in a centrifuge for 5 minutes at 12000rpm and 4˚C to spin out the insoluble 
matrix from the sample. 25μL of the soluble sample was removed from each 
microcentrifuge tube and transferred to the black 96-well plate. 75μL of 1x TE was added 
to each well to bring the sample volume 100μL. To prepare for the standard curve, the 
DNA standards were made with varying concentrations of DNA standard and 1xTE 
100μL of each standard dilution were added to separate wells on the plate (See Figure 3). 
The Picogreen reagent (Molecular probes catalog #P-11496) was then diluted 1:200 in 1x 
TE and made the day of the assay. Due to its light and time sensitivity, it was wrapped in 
aluminum foil. 100μL of the diluted Picogreen reagents were added to each well, covered 
with foil, and placed on a shaker for 2-5 minutes. The plate was then read on a 
fluorescent plate reader at excitation/emission of 285/20, 530/25nm (See Figure 3). The 














Figure 3- Representative image of DNA Plate assay and standard 




Protein Assay The protein assay was performed in a clear 96-well plate. 25μL of 
the soluble extract was first transferred to the 96-well plate from each microcentrifuge 
tube. As per the manufacturer's instructions, the working reagent (WR) for the protein 
assay was prepared using volume to volume ratios: 25:24:1 ratio of reagents MA:MB:MC 
from the Protein Assay Kit (Thermo Scientific Product No. 23225). For the total WR 
volume required for the assay, the formula (# of standards + # of unknowns + 2)(150μL 
WR) was used. The WR is not light sensitive but does need to be made on the day of 
assay. 125μL of 1X TE were added to each sample well and 100μL of 1X TE were added 
to each standard well. Then 25μL of extraction buffer was added to each standard well. 
150μL of the WR was then added to each well and placed on the shaker for 30 seconds. 
The diluted Albumin (BSA) Standards are then prepared (See Figure 4). To prepare the 














After the standards were made, 25μL of the standard were transferred to the wells in the 
96-well plate that contained 1X TE and WR. The plate was then incubated at 37˚C for 2 
hours and covered using a sealing tape. It was important to limit the incubations to less 
than or equal to 37˚C, otherwise there is a chance that high background and aberrant 
color development may occur. After 2 hours of incubation, plates were cooled to room 
temperature and read the absorbance at 562nm.  
Figure 4- Representative image of Protein Plate assay and standard 




Hydrolysis of Insoluble Matrix The insoluble matrix in the microcentrifuge and 
the remainder of the soluble materials were then subjected to acid hydrolysis for the 
analysis of total calcium and collagen. 13.0μL of 12N HCl is added to each 
microcentrifuge tube and vortexed. This was left at room temperature for 30 minutes to 
allow for extraction. After 30 minutes, 55μL was removed for the calcium assay while the 
remaining sample was adjusted to final 6N HCL by adding 92μL of 12N HCl to the 














blocks in the fume hood and hydrolyzed for 3 hours at 120O˚C. After 3 hours, the 
microcentrifuge tubes were removed and cooled to room temperature. The samples were 
then spun down in a centrifuge to remove any particulate at 12000 RPM for 5 minutes at 
18˚C. 200μL from each microcentrifuge tube were removed and transferred to a clear 96-
well plate in preparation for the Hydroxyproline assay. This 96-well plate was first dried 
to remove the acid by incubating in a vacuum oven at 60˚C for 24 hours.  
Calcium Assay The assay is performed using a clear 96-well microplate, using 
the Calcium Colorimetric Assay Kit (Sigma-Aldrich Catalog No. MAK022). Prior to 
starting, the calcium assay buffer (Sigma-Aldrich Catalog No. MAK022A) and 
chromogenic reagent (Sigma-Aldrich Catalog No. MAK022B) were allowed to come to 
room temperature before use. 55μL of calcium extract from hydrolysis of the insoluble 
matrix was transferred into the microplate. To prepare the calcium standard curve, 10μL 
of 400nM calcium standard stock (Sigma-Aldrich Catalog No. MAK022C) in 990μL of 
1N HCl was made to a final concentration of 5nM of stock for the curve (0.2μg/μL) (see 
Figure 5). Once the standard was prepared, add 50μL of each standard to a separate well 
of the 96-well plate. After, add 60μL of calcium assay buffer followed by 90μL of 
chromogen to each well of the plate. Cover the plate with foil and incubated the plate at 










Figure 5- Representative image of Calcium Plate assay and standard curve 
Representative Calcium assay standard curve (Patients 231, 237) 
 
 
Hydroxyproline Assay This assay was performed in a clear 96-well microplate 
using a Hydroxyproline Assay Kit (Sigma-Aldrich Catalog No. MAK008). The oxidation 
buffer (Sigma-Aldrich Catalog No. MAK008A) and 4-(Dimethylamino) benzaldehyde 
(DMAB) (Sigma-Aldrich Catalog No. MAK008D) concentrate were used at room 
temperature. These two assay reagents are stable for 2-3 hours after preparation, so they 
should be prepared after sample preparation and just prior to the start of the assay. It 
should also be considered to make as much reagent that is needed for the number of 
samples and standards to be assayed. To prepare the Chloramine T/Oxidation Buffer 
Mixture, a total of 100μL per well was needed; therefore, 6μL of Chloramine T 
Concentrate (Sigma-Aldrich Catalog No. MAK008B) and 94μL of Oxidation Buffer were 
multiplied by the number of samples and standards to determine the amount needed. To 
prepare the DMAB/Perchloric Acid/Isopropanol Solution, a total of 100μL per well was 
needed; therefore, 50μL of DMAB concentrate and 50μL of Perchloric Acid/isopropanol 














standards. To make the hydroxyproline standards for colorimetric detection, 10μL of the 
1 mg/mL hydroxyproline Standard Solution (Sigma-Aldrich Catalog No. MAK008E) was 
diluted with 90μL of ultrapure water to prepare a 0.1mg/mL standard solution. Then 0, 2, 
4, 6, 8, and 10μL of the 0.1 mg/mL hydroxyproline standard solution was placed into the 
96-well plate generating the 0 (blank), 0.2, 0.4, 0.6, 0.8, and 1.0μg concentration per well 
standards. After, 100μL of the Chloramine T/Oxidation Buffer Mixture was added to 
each sample and standard well. This solution was then incubated at room temperature for 
5 minutes. Then 100μL of the diluted DMAB Reagent was added to each sample and 
standard well (See Figure 6). This was allowed to be incubated for 24-48 hours at 60˚C. 
After incubation, the absorbance was read at 560nm.   
Figure 6- Representative image of Hydroxyproline Plate assay and standard curve. 






 Patients (N=10) in this study underwent total hip arthroplasty surgery at Boston 

















marrow harvested from remaining aspirates from the placement of the acetabular cup. 
The patients’ ages ranged from 36 to 58 years old and had an average of 47 years old. For 
the purpose of this study, 10 patient samples were chosen based on those, which had 
previously been assessed for osteogenic function in primary cultures. Prior data for the 
primary MSC growth and osteogenic assay were derived from a prior study (Margaret 
Dunlap, Demographic Variation in Bone-Marrow Derived Mesenchymal Stem Cell 
Analytes, 2020 Masters of Medical Sciences Boston University Graduate Medical 
Sciences) and used to compare to the current study. Patients identified themselves as 
White (N=5), Black (N=3), Hispanic (N=1), Asian (N=0), and not available (N=1). The 
BMI of these patients ranged from 23.29 to 41.39. For the purpose of this study, those 
who had a BMI greater than or equal to 30 were categorized as overweight, while the 
remaining were categorized as healthy. The patients’ vitamin D levels were also taken. 
Those with levels less than 19.9 (N=3) were considered deficient and those above 20 
were considered within the normal range. In addition, it was noted whether they smoked 
or not, one patient identified as a smoker, three identified as non-smokers, and the 
remaining six identified as former smokers (See Table 1). 
Table 1- Patient Demographics 
Patient 







Smoker Vitamin D 
226 M 50 N/A 27.31 No No No NA 
231 F 37 White 34.76 No No Former 13.4 
232 F 52 African American 35.79 
Pre-
diabetes No Former 39.7 
236 M 41 Hispanic or Latino 41.39 No No Former 14.1 
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237 M 54 White 31 Pre-diabetes No Former 26 
238 F 56 White 38.03 No No no 24.4 
240 M 36 White 23.29 No Yes*  Former 40.8 
242 M 58 African American 24.03 No No Yes 29.6 
246 M 39 African American 28.87 No No No 10 
247 M 47 White 30.63 No No Former 24.6 
*Patient was on prednisone on and off 
Biochemical Assay Data and Statistical Analysis 
 Any wells that resulted in values of 0 for a DNA measurement were excluded 
when taking the well averages across a patient plate. Prior statistical correlations to 
comorbidities for the primary cultures were based on the analysis presented in Dunlap 
2020 while these findings involve a smaller data set, so our conclusions are preliminary 
in nature until the additional matched samples are assessed. For the analysis for each 
biochemical assay, the optical density of the blank was subtracted from the optical 
density as well as standard curve values that were measured. Once the subtracted values 
were found, they were graphed with the line of best fit to find the concentration of each 
well of the biochemical marker that was being measured. The concentrations found were 
then converted to nanograms or micrograms per mL, depending on the biochemical 
marker. Then the average of the 11 wells were taken to determine the patient’s mean 
concentration values of DNA, ALP, calcium, hydroxyproline, and protein. To determine 
a significant difference in ALP, calcium, hydroxyproline, and protein normalized values 
between the primary and secondary cultures, a one-way ANOVA was conducted. The p-






 The first question that is addressed in this study is whether there is a greater 
environmental impact on osteogenic and mineralization potential in primary versus sub 
cultivated cultures. Therefore, a comparison between the patient’s primary and secondary 
cultures was compared for significant difference in biochemical markers based on 
normalized values. Graphical assays for each of the assays are presented first while a 
summary of the statistical analysis is presented at the end of this section in Table 2. 
The next question investigated in this study was to determine the positive 
correlation between DNA, ALP, calcium, and hydroxyproline. With an increase in MSC 
growth and mineralization, we hypothesized that there would also be an increase in the 
overall levels of the expressed biochemical markers. A comparison was made within each 
biochemical marker. 
Biochemical Assay Variables Comparison 
ALP There was no significant difference between the DNA normalized values of 
primary and secondary ALP values. The mean ALP normalized values for the primary 
and secondary cultures were 0.5501 and 0.5800 respectively (See Table 2). Because the 
F-ratio=0.0156 and p-value=0.9019, the results do not show significance at p<0.05. 
However, the overall concentration values were significantly different between the ALP 
concentrations of the two cultures. The mean ALP concentration values for the primary 
and secondary were 118.7607 nM/ml and 831.1413 nM/ml respectively (See Table 2). 
Because the F-ratio=9.2226 and p-value=0.0071, the results show significance at p<0.05. 
Therefore, with a large f-ratio value, we can reject the null hypothesis and conclude that 
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there is a significant difference in ALP concentration between the primary and secondary 
cultures (See Figure 7).  
Figure 7- Representative Images of Primary and Secondary Culture Comparisons 
for ALP (primary culture data acquired from Margaret Dunlap’s thesis (Demographic 
Variation in Bone-Marrow Derived Mesenchymal Stem Cell Analytes, 2020) A) 


















































Calcium There was not a significant difference between normalized calcium 
concentrations. The mean calcium normalized values for the primary and secondary 
cultures were 147.1798 and 14.8552 respectively (See Table 2). Because the F-
ratio=1.9668 and p-value=0.1778, the results do not show significance at p<0.05. 
Therefore, we cannot reject the null hypothesis and conclude that there is not a significant 
difference in calcium normalized values between the primary and secondary cultures. 
Furthermore, looking at the concentration values of the calcium, a significant difference 
between calcium concentrations was not evident after running an ANOVA. The 
mean calcium concentrations for the primary and secondary cultures were 6663.2604ng 
and 13628.5772ng respectively. Because the F-ratio=2.7241 and p-value=0.1162, the 
results do not show significance at p<0.05. Therefore, we cannot reject the null 
hypothesis and conclude that there is not a significant difference in calcium concentration 
between the primary and secondary cultures. Despite not showing significant difference, 


















Figure 8- Representative Images of Primary and Secondary Culture Comparisons 
for Calcium (primary culture data acquired from Margaret Dunlap’s thesis 
(Demographic Variation in Bone-Marrow Derived Mesenchymal Stem Cell Analytes, 





















































Hydroxyproline There was not a significant difference between the primary and 
secondary hydroxyproline normalized values. The mean hydroxyproline concentration 
for the primary and secondary cultures were 3.1753 and 0.8871 respectively (See Table 
2). Because the F-ratio=2.88 and p-value=0.1069, the results do not show significance at 
p<0.05. Therefore, with a low f-ratio value, we cannot reject the null hypothesis and 
conclude that there is no significant difference in hydroxyproline normalized values 
between the primary and secondary cultures. However, looking at the concentration 
values, a significant difference was found between the primary and secondary cultures. 
There was a significant difference between hydroxyproline concentrations. The mean of 
hydroxyproline concentrations for the primary and secondary cultures were 89.4594ng 
and 1204.2877ng respectively. Because the F-ratio=25.9880 and p-value=0.0001, the 
results show significance at p<0.05. Therefore, with a large f-ratio value, we can reject 
the null hypothesis and conclude that there is a significant difference in hydroxyproline 
concentration between the primary and secondary cultures (See Figure 9).  
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Figure 9- Representative Images of Primary and Secondary Culture Comparisons 
for Hydroxyproline (primary culture data acquired from Margaret Dunlap’s thesis 
(Demographic Variation in Bone-Marrow Derived Mesenchymal Stem Cell Analytes, 
2020) A) Normalized Hydroxyproline values comparison B) Concentration 






 DNA To investigate the difference in mineralization of the MSC cultures between 













































direct comparison cannot be made with concentration values, it is worth noting that there 
was a significant difference in DNA concentration between the two cultures. An ANOVA 
was run to determine significance differences. The mean DNA concentrations for primary 
and secondary cultures were 386.8162 ng/ml and 2397.4118 ng/ml respectively. As the f-
ratio=13.7252 and had a p-value=0.0016, the results showed significance at p<0.05 (See 
Figure 10). Therefore, with a large f-ratio value, we can reject the null hypothesis and 
conclude that there is a significant difference in DNA concentration between the primary 
and secondary cultures.  
Figure 10- Representative Image of Primary and Secondary Culture Comparisons 
for DNA (primary culture data acquired from Margaret Dunlap’s thesis (Demographic 
Variation in Bone-Marrow Derived Mesenchymal Stem Cell Analytes, 2020) 
Concentration Hydroxyproline values comparison 
 
 
Protein There was not a significant difference between the primary and 
secondary protein normalized values. The mean of normalized protein values for the 
primary and secondary cultures were 2.6171 and 19.1382 respectively (See Table 2). 



























p<0.05. Therefore, with a low f-ratio value, we cannot reject the null hypothesis and 
conclude that there is no significant difference in protein normalized values between the 
primary and secondary cultures. However, looking at the concentration values, a 
significant difference was found between the primary and secondary cultures. There was 
a significant difference between protein concentrations. The mean protein concentrations 
for the primary and secondary cultures were 4629.7150 μg/ml and 27791.1010 μg/ml 
respectively. Because the F-ratio=16.3859 and p-value=0.0008, the results show 
significance at p<0.05. Therefore, with a large f-ratio value, we can reject the null 
hypothesis and conclude that there is a significant difference in protein concentration 
between the primary and secondary cultures (See Figure 11).  
Figure 11- Representative Images of Primary and Secondary Culture Comparisons 
for Protein (primary culture data acquired from Margaret Dunlap’s thesis (Demographic 
Variation in Bone-Marrow Derived Mesenchymal Stem Cell Analytes, 2020) A) 
































Table 2- ANOVA Statistical Analysis for Normalized and Concentration Values of 
Each Biochemical Assay 
  Primary Secondary 
ALP N 10 10 




















Calcium N 10 10 













































Hydroxyproline N 10 10 























N 10 10 
Total Sum 3868.1620 ng/ml 23974.1180 ng/ml 
Mean 386.8162 ng/ml 2397.4118 ng/ml 
Standard Deviation 249.1153 ng/ml 1698.0119 ng/ml 
Standard Error 78.7772 ng/ml 536.9585 ng/ml 
f-ratio value 13.7252 
p-value 0.0016 
Protein N 10 10 




















*Values in parenthesis are concentration values for that biochemical assay 
 
Alizarin Stain Nodules Though there were no primary cultures to use as a 
comparison, the secondary cultures showed Alizarin staining and nodule formation 
suggesting significant evidence of mineralization for all patients. As described in the 
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methods section, Alizarin staining was scored from 0 (no staining) to two (well 
completely stained) (See Figure 12). 
Figure 12- Alizarin Stain Nodules Scored Each stain was scored between 0 and 2. 0= 
no mineralization, 1= little mineralization, 2= complete mineralization (a) Patient 226, 
Score: 1 (b) Patient 232, Score: 1 (c) Patient 240, Score: 2 (d) Patient 242, Score 2 (e) 













Biochemical Assay Variables 
 The second question proposed in this study was to determine the positive 
correlation within the biochemical markers. Therefore, a Pearson correlation coefficient 
test was run comparing DNA, ALP, calcium, and hydroxyproline for correlation within 
the group.  
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 When comparing DNA to ALP, a weak positive correlation was found. The value 
of R=0.189 and since it is closer to the value of zero, it has a weak relationship. DNA 
compared to calcium had a value of R=0.0837. This also has a R value closer to zero, 
meaning they have a weak, but positive correlation. DNA and hydroxyproline also had a 
weak positive correlation with the R=0.3513. When ALP was compared to calcium, it 
was found that they also have a weak positive correlation with a R value = 0.1396. ALP 
was also compared to hydroxyproline and it was found that they also have a moderate 
positive correlation with the R value = 0.4426. Lastly, calcium was compared to 
hydroxyproline and it was found that they have a negative moderate correlation, with a R 
value = -0.4915 (See Table 3).  
Table 3- Pearson Correlation Coefficient Results Testing for Correlation Within 









Total Sum 23974.1180 8314.1301 136285.7700 12042.8770 
Mean 2397.4118 831.1413 13628.5772 1204.2877 
R value DNA + ALP: 0.189 
DNA + Calcium: 0.0837 
DNA+ Hydroxyproline: 0.3513 
ALP + Calcium: 0.1396 
ALP + Hydroxyproline: 0.4426 
Calcium + Hydroxyproline: -0.4915 
R2 value DNA + ALP: 0.0357 
DNA + Calcium: 0.0088 
DNA+ Hydroxyproline: 0.1234 
ALP + Calcium: 0.00195 
ALP + Hydroxyproline: 0.1959 











Comparison Between Primary and Secondary Cultures 
 To determine the extent to which environmental comorbidities affect the 
expression of osteogenic biochemical markers and mineralization of marrow stromal 
cultures primary and secondary cultures were compared. It was hypothesized that there 
would be a significant difference between the primary and secondary cultures in terms of 
normalized values within each biochemical marker of the primary and secondary 
cultures. However, it was found that when comparing the normalized assayed values 
there was no significance. However, when comparing the overall concentration values of 
DNA, ALP, calcium, hydroxyproline, and protein, it can be seen that there were much 
greater concentration values in the secondary than primary cultures. 
Biochemical Markers 
Total DNA and protein content were measured to evaluate the overall growth and 
metabolic activities of the primary and secondary cultures.  The assessment of DNA 
content between the primary and secondary cultures showed that there was an overall 
greater growth of the secondary cultures compared to the primary cultures. .  Interestingly 
when examining the normalized protein values the normalized values showed no 
significant differences between the primary and secondary cultures suggesting that the 
overall metabolic activity of the cultures were the same. These data suggest that there 
was an impact on the overall cell number and/or initial growth of the primary MSC 
cultures, possibly due to the patient comorbidities.  However, on a per cell basis the 
overall metabolic activity was similar between the primary and secondary MSC cultures.  
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 The examination of parameters that assessed osteogenic activity included alkaline 
phosphatase enzyme activity, overall accumulation of collagen via measurements of 
hydroxyproline content, and total accumulation of minerals via the measurements of 
calcium. When looking at the means of the normalized values of ALP, there was no 
significant difference between the primary and secondary cultures while the overall mean 
values of the secondary culture was slightly increased.  However, the difference in 
concentrations obtained from the biochemical assays showed significant differences. The 
secondary culture had a mean of 621.98 nM/ml, while the primary only had 11.8105 
nM/ml. The inconsistency between the normalized value and the evidence of increased 
mineralization and growth could be due to the presence of outliers within the individual 
plate assays. As an example the DNA values obtained for patient 226 ranged from 0.831 
to 204.374 thus producing extreme normalized ALP values ranging from high to low 
concentration values over varying DNA values skewing  the overall values for the data. 
Furthermore, having a small sample size would further exacerbate outliers within the 
data.  
 The calcium data obtained from the secondary culture had a greater normalized 
mean value compared to the primary culture with 162.2523and 34.7161 respectively. 
However, this difference was not significant. The calcium concentration prior to 
normalization  was also not significant.  However, it is worth noting that the mean 
calcium concentration for the secondary culture was increased compared to the primary 
culture with a mean of 3344.994 and 1521.4807 respectively. The lack of significant 
difference in the values could be due to a lack of data for a few of the patients. Although 
	
39 
the primary cultures were not grown and analyzed in this project the larger number of 
wells showing a zero-concentration value is clearly the result of the broader variability in 
expansion of stem cells or progenitors within individual wells that is lost when these cells 
are expanded and replated. When conducting this experiment again, it would be helpful 
to have a greater sample size so that the data can be compared over a much larger sample 
size.  
 Although it was hypothesized that the secondary cultures would have greater 
normalized values than secondary values, this was not evident in the hydroxyproline 
normalized values. In fact, the primary cultures had a greater normalized mean value than 
the secondary. Upon further inspection however, it can be seen that the secondary 
hydroxyproline concentrations had a greater mean than the first. One possible difference 
for the overall differences was that the secondary cultures were grown for one week less 
than the primary cultures under mineralizing conditions.   
  Further mineralization analysis was conducted with the Alizarin Nodule Stain. It 
was evident that layers of mineralization occurred within the wells of the plate, as they 
stained completely. For those wells with lack of stains, it was consistent with decreased 
values in DNA, ALP, calcium, hydroxyproline, and protein acquired for the patient. For 
future analyses, alizarin stains could be run for both primary and secondary cultures and 
compared side-by-side to reduce variabilities that occur at running the experiments at 
separate times.  
Correlation Within Biochemical Markers  
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 The second hypothesis within this study was determining if there were positive 
correlations between the biochemical markers, DNA, ALP, calcium, and hydroxyproline. 
A Spearman rho test was run to determine correlation and it was found that within all the 
biochemical markers, they had positive, but weak correlations with the exception of 
calcium and hydroxyproline. However, for calcium and hydroxyproline a negative 
correlation was observed. This correlation is significant though and consistent with what 
is observed as mineralization proceeds both in vivo and in vitro as the organic fraction of 
bone material decreases as mineral is deposited in the matrix (Gerstenfeld, 1987).  
Issues, Limitations, and Future Direction  
The recurrent issue within this study is the small sample size and lack of 
consistency between the data in the primary and secondary cultures. Having a small 
sample size allowed for a much greater range in concentration values, including outliers 
that skewed the data, especially for normalized values. In addition, although 
comorbidities were noted such as diabetes, BMI, and smoking status, there could be other 
factors that may have contributed to the variability of bone mineralization. Furthermore, 
as this was the first time growing out cells from frozen stock, there were issues with 
growing out cells at the start of this study. When repeating this experiment, protocols in 
growing out frozen cells will be more solidified, allowing for better growth and 
mineralization for all patients. Furthermore, conducting these two experiments at two 
separate times could have caused additional mishaps, resulting in varying data for the 
biochemical assays. In addition, some variability in the data could have risen from the 
assay kits. Problems with the calcium and protein assays could have led to 
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uninterpretable data. For example, issues with the protein standards could have resulted 
in errors with calculating the concentration values. Therefore, given the limitations, 
results should be interpreted with caution.    
This study examined the impact of comorbidities on patients by comparing 
mineralization of primary and secondary subcultures of MSCs. Initially the hypothesis 
was that there would be a significant difference between the primary and secondary 
cultures; however, data showed that in fact there was no significant difference between 
the two subcultures. On the other hand, when observing just the concentration values, the 
data showed drastic increases in concentration values from secondary to primary cultures. 
Furthermore, the second hypothesis predicted that there would be positive correlations 
among the biochemical markers like DNA, ALP, calcium, hydroxyproline, and protein, 
and showed that although they were weak correlations, there were in fact positive 
correlations, with the exception of calcium and hydroxyproline. As osteoporosis 
continues to be a major and increasing health problem for the ageing populations, it is 
important to understand the mechanisms and pathogenesis of osteoporosis, so that 
interventions for both individuals and communities can utilize effective prevention 
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